Supplementary Table 2 shows the direct comparison of the F-statistics and effect size (ηp2) between CSF p-tau/Aβ42 and the other two core Alzheimer’s disease reference biomarkers (i.e. CSF Aβ42 and CSF p-tau). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.